Allergan Unredacted Emails To Refute Ackman ClaimsMark Melin
The voluminous number of emails and official documents showing private conversations between Allergan, Inc. (NYSE:AGN) executives and outside consultants, to be public in court tomorrow, were unredacted by Allergan with the goal to refute claims by Pershing Square’s Bill Ackman, a source with direct involvement in the situation said.
This content is exclusively for paying members of ValueWalk Premium
Gain Exclusive Access to the Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with ValueWalk Premium
Get Started Now with a FREE 7-Day Trial
If you are a current ValueWalk Premium member and are having an account error please clear cache and cookies. If that does not work, email [email protected] or click Chat.